Literature DB >> 31489325

Histologic and molecular features of small well-differentiated pancreatic neuroendocrine tumors associated with the development of liver metastases.

Paula Jiménez-Fonseca1, Patricia Morales Del Burgo2, Felipe Alvarez-Manceñido3.   

Abstract

Entities:  

Year:  2019        PMID： 31489325      PMCID： PMC6700015          DOI： 10.21037/hbsn.2019.04.10

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  7 in total

Review 1.  The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia.

Authors:  Frediano Inzani; Gianluigi Petrone; Guido Rindi
Journal:  Endocrinol Metab Clin North Am       Date:  2018-07-11       Impact factor: 4.741

2.  Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.

Authors:  Joo Young Kim; Jacqueline A Brosnan-Cashman; Soyeon An; Sung Joo Kim; Ki-Byung Song; Min-Sun Kim; Mi-Ju Kim; Dae Wook Hwang; Alan K Meeker; Eunsil Yu; Song Cheol Kim; Ralph H Hruban; Christopher M Heaphy; Seung-Mo Hong
Journal:  Clin Cancer Res       Date:  2016-09-23       Impact factor: 12.531

3.  Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).

Authors:  Elena Martin-Perez; Jaume Capdevila; Daniel Castellano; Paula Jimenez-Fonseca; Ramon Salazar; Adolfo Beguiristain-Gomez; Vicente Alonso-Orduña; Purificacion Martinez Del Prado; Carles Villabona-Artero; Jose A Diaz-Perez; Antonio Monleon; Monica Marazuela; Vanessa Pachon; Javier Sastre-Valera; Isabel Sevilla; Angel Castaño; Rocio Garcia-Carbonero
Journal:  Neuroendocrinology       Date:  2013-09-19       Impact factor: 4.914

4.  Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).

Authors:  Barbara Nuñez-Valdovinos; Alberto Carmona-Bayonas; Paula Jimenez-Fonseca; Jaume Capdevila; Ángel Castaño-Pascual; Marta Benavent; Jose Javier Pi Barrio; Alex Teule; Vicente Alonso; Ana Custodio; Monica Marazuela; Ángel Segura; Adolfo Beguiristain; Marta Llanos; Maria Purificacion Martinez Del Prado; Jose Angel Diaz-Perez; Daniel Castellano; Isabel Sevilla; Carlos Lopez; Teresa Alonso; Rocio Garcia-Carbonero
Journal:  Oncologist       Date:  2018-01-12

Review 5.  The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction.

Authors:  G Rindi; G Petrone; F Inzani
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

6.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.

Authors:  Arvind Dasari; Chan Shen; Daniel Halperin; Bo Zhao; Shouhao Zhou; Ying Xu; Tina Shih; James C Yao
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777

7.  Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases.

Authors:  Antonio Pea; Jun Yu; Luigi Marchionni; Michael Noe; Claudio Luchini; Alessandra Pulvirenti; Roeland F de Wilde; Lodewijk A Brosens; Neda Rezaee; Ammar Javed; Peter Chianchiano; Stefano Gobbo; Paolo Regi; Roberto Salvia; Claudio Bassi; Jin He; Matthew J Weiss; John L Cameron; G Johan A Offerhaus; Ralph H Hruban; Rita T Lawlor; Aldo Scarpa; Christopher M Heaphy; Laura D Wood; Christopher L Wolfgang
Journal:  Ann Surg       Date:  2020-03       Impact factor: 13.787
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.